{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:35:22Z","timestamp":1789061722224,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cosmo Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03804-3","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:46:46Z","timestamp":1743738406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth"],"prefix":"10.1186","volume":"25","author":[{"given":"Bradley A.","family":"Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rogova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charandeep","family":"Waraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Averill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"publisher","unstructured":"Pimentel M, Saad RJ, Long MD, Rao SS. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. February 2020;115(2):165\u201378. https:\/\/doi.org\/10.14309\/ajg.000000000000050.","DOI":"10.14309\/ajg.000000000000050"},{"key":"3804_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/flgastro-2022-102163","volume":"14","author":"JF Ahmed","year":"2023","unstructured":"Ahmed JF, Padam P, Ruban A. Aetiology, diagnosis, and management of small intestinal bacterial overgrowth. Frontline Gastroenterol. 2023;14:149\u201354.","journal-title":"Frontline Gastroenterol"},{"key":"3804_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.gtc.2021.02.007","volume":"50","author":"A Berumen","year":"2021","unstructured":"Berumen A, Edwinson AL. Post-Infection irritable bowel syndrome. Gastroenterol Clin North Am. 2021;50:445\u201361. https:\/\/doi.org\/10.1016\/j.gtc.2021.02.007.","journal-title":"Gastroenterol Clin North Am"},{"key":"3804_CR4","doi-asserted-by":"publisher","unstructured":"Skrzyd\u0142o-Radomanska B, Cukrowska B. How to recognize and treat small intestinal bacterial overgrowth? J Clin Med. 2022;11(6017). https:\/\/doi.org\/10.3390\/jcm11206017.","DOI":"10.3390\/jcm11206017"},{"key":"3804_CR5","doi-asserted-by":"publisher","first-page":"e00567","DOI":"10.14309\/ctg.0000000000000567","volume":"14","author":"A Tansel","year":"2023","unstructured":"Tansel A, Levinthal DJ. Understanding our tests: Hydrogen-methane breath testing to diagnose small intestinal bacterial overgrowth. Clin Translational Gastroenterol. 2023;14:e00567. https:\/\/doi.org\/10.14309\/ctg.0000000000000567.","journal-title":"Clin Translational Gastroenterol"},{"issue":"6","key":"3804_CR6","doi-asserted-by":"publisher","first-page":"e8860","DOI":"10.7759\/cureus.8860","volume":"12","author":"TO Achufusi","year":"2020","unstructured":"Achufusi TO, Sharma A, Zamora EA, Manocha D. Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods. Cureus. 2020;12(6):e8860. https:\/\/doi.org\/10.7759\/cureus.8860.","journal-title":"Cureus"},{"key":"3804_CR7","unstructured":"RedHill Biopharma Inc. Aemcolo (rifamycin) [prescribing information]. Raleigh, NC. February; 2021."},{"key":"3804_CR8","doi-asserted-by":"publisher","unstructured":"Nardelli S, Pisani LF, Tontini GE, Vecchi M, Pastorelli L. MMX technology and its application in Gastrointestinal diseases. Therapeutic Adv Gastroenterol. 2017;10(7). https:\/\/doi.org\/10.1177\/1756283X17709974.","DOI":"10.1177\/1756283X17709974"},{"issue":"12","key":"3804_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1080\/17474124.2021.2005579","volume":"15","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang L, Hou X. Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15(12):1385\u201399. https:\/\/doi.org\/10.1080\/17474124.2021.2005579.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3804_CR10","unstructured":"Commonwealth Laboratories. Breath Test Patient Instructions. Retrieved from https:\/\/commdx.com\/wp-content\/uploads\/2024\/01\/LA-013-Rev-M-SIBO-10-Tube-Lactulose-DIGITAL.pdf"},{"key":"3804_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMC Med. 2010;8:18.","journal-title":"BMC Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03804-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:46:50Z","timestamp":1743738410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03804-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03804-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Advarra Institutional Review Board on October 2, 2019, with protocol # PRO00038302. All study subjects received and signed an informed consent form prior to participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"4. We confirm that this work, including VAS questionnaires (VAS1-3) included in this protocol is original, has not been previously published elsewhere, and is not under consideration by another journal or book (print or electronic). All VAS questionnaires used in our study were developed for this study and have not been previously published elsewhere.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study and other materials publications"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}